KB

Katie Bodner Spielberg

Principal at 5AM Ventures

Boston, Massachusetts

Overview 

Katie Bodner Spielberg is currently a Principal at 5AM Ventures in Boston, Massachusetts, with a background that includes roles as a Senior Associate, Analyst, and Fellow within the same firm. She holds a Doctor of Philosophy (Ph.D.) and M.S. from Stanford University and a Bachelor of Science (S.B.) from the Massachusetts Institute of Technology. Highlights of Katie Bodner Spielberg's career include her progression to the role of Principal at 5AM Ventures and her experience as a Postdoctoral Research Fellow at Stanford University, showcasing her expertise in the BioTech sector and her academic achievements from leading institutions like Stanford and MIT.

Work Experience 

5V

5AM Ventures

  • Principal

    2024 - Current

  • Senior Associate

    2023 - 2024

  • Associate

    2022 - 2023

  • Analyst

    2021 - 2021

  • Fellow

    2020 - 2020

5AM Ventures is a venture capital firm that aims to finance seed and early-stage life sciences companies.

5amventures.com

Lifordi Immunotherapeutics

  • Board Observer

    2023

GA

GlycoEra AG

  • Board Observer

    2021

SU

Stanford University

  • Postdoctoral Research Fellow

    2020 - 2020

  • Ph.D. Candidate

    2015 - 2020

    * Funded by the Hertz-Draper Fellowship and the Stanford SGF and EDGE-STEM Fellowships * Thesis: "An Engineering Approach to Uncover Interactions Between Bacteriophages, Bacteria and Mammalian Cells" * Three first author publications in Cell Systems, STAR Protocols and Trends in Microbiology (doi.org/10.1016/j.cels.2020.02.006, doi.org/10.1016/j.xpro.2020.100084,https://doi.org/10.1016/j.tim.2020.10.014).

RW

Ron Weiss Lab at MIT

  • Research Assistant

    2012 - 2015

    • Co-authored two publications (Nature Chemical Biology and Expert Review of Vaccines doi.org/10.1038/s41589-018-0146-9 and doi.org/10.1586/14760584.2015.997714) and a patent: U.S. Patent Application No. 15/509,258 (2017). • Earned a Gold Medal at the iGEM (International Genetically Engineered Machines) America’s East Regional Competition.

G

Genentech

  • Intern, Late Stage Cell Culture

    2014 - 2014

    • Engineered E. coli cell lines to reduce acetate accumulation in recombinant protein production during fed-batch fermentation and characterized growth in 10-L bioreactors

Genentech specializes in genetic testing and personalized medicine.

gene.com

Education 

Articles About Katie

Relevant Websites